A detailed history of Ikarian Capital, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 8,741 shares of ALNY stock, worth $2.22 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
8,741
Previous 1,500 482.73%
Holding current value
$2.22 Million
Previous $364,000 560.44%
% of portfolio
0.42%
Previous 0.15%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$233.81 - $287.01 $2.04 Million - $2.51 Million
8,741 New
8,741 $2.4 Million
Q1 2024

May 15, 2024

BUY
$146.51 - $198.2 $7.55 Million - $10.2 Million
51,541 New
51,541 $7.7 Million
Q3 2022

Nov 14, 2022

SELL
$138.54 - $232.0 $8.1 Million - $13.6 Million
-58,437 Reduced 95.43%
2,800 $560,000
Q2 2022

Aug 12, 2022

BUY
$120.42 - $169.29 $7.23 Million - $10.2 Million
60,000 Added 4850.44%
61,237 $8.93 Million
Q1 2022

May 13, 2022

BUY
$127.18 - $173.91 $5,341 - $7,304
42 Added 3.51%
1,237 $201,000
Q4 2021

Feb 14, 2022

SELL
$159.56 - $209.29 $42,442 - $55,671
-266 Reduced 18.21%
1,195 $204,000
Q3 2021

Nov 15, 2021

BUY
$169.75 - $207.73 $248,004 - $303,493
1,461 New
1,461 $276,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.